Evaluation of Therapeutic Effects of MLS® on the Outcomes of Flapless Dental Implant Surgery in Posterior Maxilla of Post Menopause Women.

N. Doan, Q.T. Duong
Energy for Health [18], 2019

The purpose of this study is to evaluate the therapeutic effects of MLS® on clinical outcomes of flapless dental implants using split mouth study in post menopause women age 50 years or over. This is a retrospective split mouth study involving the analysis of dental records of post-menopause patients undergoing bilateral implant surgery in the posterior maxilla. Sixty-five implants with no augmentative procedures were selected from 26 patients. Flapless implant technique was used for both sides of the jaw. The patients were divided into two groups: 32 implants in the sham group and, 33 implants in the MLS® group. Treatments were performed at day one, day 7 and day 28. Results were analyzed by: Satisfaction, Implant Survival, Visual Analogue Scale (VAS), Periotest, X-ray assessment. MLS® treatment had slightly better outcomes respect to the control side (survival rate: 100.0% and 96.9%), MLS® group had less pain and swelling and better overall satisfaction at one day and one week (*P<0.05). No difference was observed in bleeding and speech impairment. No significant difference in bone resorption at 3 months. After 6 months, bone change in the control group vs the test group was statistically significant [-0.56 (±0.52) vs +0.12 (±0.50), **P<0.05]. No statistical dissimilarity in Periotest Value (PTV). In flapless implant surgery, MLS® treatment is an adjunctive minimally invasive, and innovative method that can deliver a significantly superior early phase satisfaction, minimal bone loss, less pain, less complications, and similar PTV respect to the control side.